177 related articles for article (PubMed ID: 25408581)
21. Prognostic importance of mitral regurgitation complicated by acute myocardial infarction during a 5-year follow-up period in the drug-eluting stent era.
Kim TH; Lee KY; Choi Y; Park HW; Lee YS; Koh YS; Park HJ; Kim PJ; Chang K; Chung WS; Kim DB; Her SH; Park CS; Lee JM; Kim HY; Yoo KD; Jeon DS; Ahn Y; Jeong MH; Seung KB
Coron Artery Dis; 2016 Mar; 27(2):109-15. PubMed ID: 26626143
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
[TBL] [Abstract][Full Text] [Related]
23. Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function.
Bollati M; Gerasimou A; Sillano D; Biondi-Zoccai G; Garrone P; Moretti C; Sciuto F; Omedé P; Trevi GP; Sheiban I
Catheter Cardiovasc Interv; 2010 Mar; 75(4):586-93. PubMed ID: 20088012
[TBL] [Abstract][Full Text] [Related]
24. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
[TBL] [Abstract][Full Text] [Related]
25. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
27. Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.
Kim J; Lee JM; Choi KH; Rhee TM; Hwang D; Park J; Ahn C; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Choi SH; Gwon HC
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29449272
[TBL] [Abstract][Full Text] [Related]
28. Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era.
Song YB; Lee SY; Hahn JY; Choi SH; Choi JH; Lee SH; Hong KP; Park JE; Gwon HC
Heart Vessels; 2012 Sep; 27(5):433-42. PubMed ID: 21769495
[TBL] [Abstract][Full Text] [Related]
29. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
[TBL] [Abstract][Full Text] [Related]
30. Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction.
Sardi GL; Gaglia MA; Maluenda G; Torguson R; Laynez-Carnicero A; Ben-Dor I; Hauville C; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2012 Feb; 109(3):344-51. PubMed ID: 22112742
[TBL] [Abstract][Full Text] [Related]
31. Long-term prognosis of complete percutaneous coronary revascularisation in patients with diabetes with multivessel disease.
Jiménez-Navarro MF; López-Jiménez F; Barsness G; Lennon RJ; Sandhu GS; Prasad A
Heart; 2015 Aug; 101(15):1233-9. PubMed ID: 25882502
[TBL] [Abstract][Full Text] [Related]
32. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
[TBL] [Abstract][Full Text] [Related]
33. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
[TBL] [Abstract][Full Text] [Related]
34. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
[TBL] [Abstract][Full Text] [Related]
35. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
[TBL] [Abstract][Full Text] [Related]
36. [Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].
Jiang L; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Gao LJ; Song L; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1058-1066. PubMed ID: 29325366
[No Abstract] [Full Text] [Related]
37. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
[TBL] [Abstract][Full Text] [Related]
39. Long-term clinical outcomes of the one-stent technique versus the two-stent technique for non-left main true coronary bifurcation disease in the era of drug-eluting stents.
Koh YS; Kim PJ; Chang K; Park HJ; Jeong MH; Kim HS; Jang Y; Gwon HC; Park SJ; Seung KB
J Interv Cardiol; 2013 Jun; 26(3):245-53. PubMed ID: 23480867
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
